PLAN ESTRATÉGICO DE INVESTIGACIÓN
LÍNEAS DE INVESTIGACIÓN
PROYECTOS DE INVESTIGACIÓN
ENSAYOS CLÍNICOS
GRUPOS COOPERATIVOS
COMUNICACIONES A CONGRESOS
PUBLICACIONES
BECAS Y RECURSOS
INVESTIGACIÓN EN OTROS LUGARES
BIBLIOGRAFIA
NUESTROS RESULTADOS

PUBLICACIONES > Año 2007

 

Leuk Lymphoma. 2007 Dec;48(12):2367-74.

Characteristics of and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation.

Puig N, De La Rubia J, Jarque I, Salavert M, Moscardó F, Sanz J, Lorenzo I, Montesinos P, Martín G, Martínez J, Sanz G, Blanes M, Sanz M.

Hematology Service, University Hospital La Fe, Valencia, Spain.

PMID: 18067012 [PubMed - indexed for MEDLINE]


 

Am J Transplant. 2007 Nov;7(11):2579-86. Epub 2007 Sep 14.

Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain.

Moreno A, Cervera C, Gavaldá J, Rovira M, de la Cámara R, Jarque I, Montejo M, de la Torre-Cisneros J, Miguel Cisneros J, Fortún J, López-Medrano F, Gurguí M, Muñoz P, Ramos A, Carratalá J.

Hospital Clínic-IDIBAPS-University of Barcelona, Barcelona, Spain. amoreno@clinic.ub.es

PMID: 17868067 [PubMed - indexed for MEDLINE]


 

Br J Haematol. 2007 Oct;139(1):70-80.

Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.

Peggs KS, Sureda A, Qian W, Caballero D, Hunter A, Urbano-Ispizua A, Cavet J, Ribera JM, Parker A, Canales M, Mahendra P, Garcia-Conde J, Milligan D, Sanz G, Thomson K, Arranz R, Goldstone AH, Alvarez I, Linch DC, Sierra J, Mackinnon S; UK and Spanish Collaborative Groups.

Department of Haematology, Royal Free and University College, London, UK. k.peggs@ucl.ac.uk

PMID: 17854309 [PubMed - indexed for MEDLINE]

 


 

J Clin Oncol. 2007 Oct 1;25(28):4452-8. Epub 2007 Sep 4.

Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics.

Rosiñol L, Oriol A, Mateos MV, Sureda A, García-Sánchez P, Gutiérrez N, Alegre A, Lahuerta JJ, de la Rubia J, Herrero C, Liu X, Van de Velde H, San Miguel J, Bladé J.

Hospital Clinic Barcelona, Barcelona, Spain.

PMID: 17785704 [PubMed - indexed for MEDLINE]

 


 

Leuk Res. 2007 Sep;31(9):1315-7. Epub 2006 Nov 7.

Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?

Mallo M, Salido M, Espinet B, Cervera J, Canellas A, Pajuelo JC, Pedro C, Florensa L, Sanz MA, Solé F.

PMID: 17092559 [PubMed - indexed for MEDLINE

 


 

Int J Hematol. 2007 Aug;86(2):186-92.

A study of incidence and characteristics of infections in 476 patients from a single center undergoing autologous blood stem cell transplantation.

Puig N, de la Rubia J, Jarque I, Salavert M, Montesinos P, Sanz J, Martín G, Sanz G, Cantero S, Lorenzo I, Sanz MA.

Hematology Service, University Hospital La Fe, Valencia, Spain.

PMID: 17875536 [PubMed - indexed for MEDLINE]

 


 

Blood. 2007 Jul 1;110(1):461-7. Epub 2007 Mar 23.

CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.

Pérez-García A, De la Cámara R, Román-Gómez J, Jiménez-Velasco A, Encuentra M, Nieto JB, de la Rubia J, Urbano-Ispizúa A, Brunet S, Iriondo A, González M, Serrano D, Espigado I, Solano C, Ribera JM, Pujal JM, Hoyos M, Gallardo D; GVHD/Immunotherapy Committee of the Spanish Group of Hematopoietic Stem Cell Transplantation.

Clinical Hematology Department, Alloreactivity Unit, Laborateri de Recerca Translacional, Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain.

PMID: 17384200 [PubMed - indexed for MEDLINE]Free Article

 


Leuk Res. 2007 Jul;31(7):947-53. Epub 2006 Nov 21.

The GST deletions and NQO1*2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia.

Barragan E, Collado M, Cervera J, Martin G, Bolufer P, Roman J, Sanz MA.

Molecular Biology Laboratory, (Dpt. Medical Pathology), Spain. barragan_eva@gva.es

PMID: 17118447 [PubMed - indexed for MEDLINE]

 


 

Bone Marrow Transplant. 2007 May;39(9):555-61. Epub 2007 Mar 12.

Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients.

Sanz J, Arriaga F, Montesinos P, Ortí G, Lorenzo I, Cantero S, Puig N, Moscardó F, de la Rubia J, Sanz G, Sanz MA.

Hematology Department, Hospital Universitario La Fe, Valencia, Spain.

PMID: 17351645 [PubMed - indexed for MEDLINE]

 


Bone Marrow Transplant. 2007 Apr;39(8):461-9. Epub 2007 Feb 26.

Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation.

Sanz MA, Labopin M, Gorin NC, de la Rubia J, Arcese W, Meloni G, Bacigalupo A, Alessandrino P, Carreras E, Iriondo A, Novitzky N, Jacobs P, Bandini G, Lo-Coco F, Frassoni F, Rocha V; Acute Leukemia Working Party (ALWP) of European Cooperative Group for Blood and Marrow Transplantation (EBMT).

Hematology Service, Hospital Universitario La Fe, Valencia, Spain. msanz@uv.es

PMID: 17322930 [PubMed - indexed for MEDLINE]

 


 

Cancer Genet Cytogenet. 2007 Apr 15;174(2):127-31.

MLL amplification in acute myeloid leukemia.

Pajuelo-Gámez JC, Cervera J, García-Casado Z, Mena-Durán AV, Valencia A, Barragán E, Such E, Bolufer P, Sanz MA.

Servicio de Hematología, Hospital Universitario La Fe, Avenida Campanar 21, Valencia 46009, Spain.

PMID: 17452254 [PubMed - indexed for MEDLINE]

 


Leukemia. 2007 Mar;21(3):446-52. Epub 2007 Jan 4.

Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.

Esteve J, Escoda L, Martín G, Rubio V, Díaz-Mediavilla J, González M, Rivas C, Alvarez C, González San Miguel JD, Brunet S, Tomás JF, Tormo M, Sayas MJ, Sánchez Godoy P, Colomer D, Bolufer P, Sanz MA; Spanish Cooperative Group PETHEMA.

Hospital Clínic, Barcelona, Spain. jesteve@clinic.ub.es

PMID: 17205057 [PubMed - indexed for MEDLINE]

 


   

Haematologica. 2007 Mar;92(3):308-14.

The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia.

Bolufer P, Collado M, Barragán E, Cervera J, Calasanz MJ, Colomer D, Roman-Gómez J, Sanz MA.

Laboratory of Molecular Biology, Department of Medical Biopathology, Hospital Universitario La Fe, Valencia, Spain. bolufer_pas@gva.es

PMID: 17339179 [PubMed - indexed for MEDLINE]Free Article

 


Haematologica. 2007 Mar;92(3):289-91.

Current treatment of acute promyelocytic leukemia.

Lo Coco F, Ammatuna E, Sanz MA.

Comment on:

Haematologica. 2007 Mar;92(3):315-22

PMID: 17339175 [PubMed - indexed for MEDLINE]


 

Br J Haematol. 2007 Feb;136(4):590-6.

Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.

Bolufer P, Collado M, Barragan E, Calasanz MJ, Colomer D, Tormo M, González M, Brunet S, Batlle M, Cervera J, Sanz MA.

Laboratory of Molecular Biology (Medical Biopathology), Hospital Universitario La Fe, Valencia, Spain. bolufer_pas@gva.es

PMID: 17367411 [PubMed - indexed for MEDLINE]

 


Eur J Haematol. 2007 Feb;78(2):102-10. Epub 2006 Nov 6

Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E; PETHEMA Group.Clinical Hematology Department, Institut Catalá d'Oncologia-Hospital Universitari Germans Trias i Pujol, Badalona, Spain.                                            PMID: 17087744 [PubMed - indexed for MEDLINE]

 


 

Leukemia. 2007 Jan;21(1):143-50. Epub 2006 Oct 5.

Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis.

Gutiérrez NC, Castellanos MV, Martín ML, Mateos MV, Hernández JM, Fernández M, Carrera D, Rosiñol L, Ribera JM, Ojanguren JM, Palomera L, Gardella S, Escoda L, Hernández-Boluda JC, Bello JL, de la Rubia J, Lahuerta JJ, San Miguel JF; GEM/PETHEMA Spanish Group.

Servicios de Hematología: Hospital Universitario de Salamanca and Centro de Investigación del Cáncer (CIC), Universidad de Salamanca-CSIC, Spain.

PMID: 17024116 [PubMed - indexed for MEDLINE]

 


Thromb Res. 2007;120 Suppl 2:S99-106.

Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?

Rickles FR, Falanga A, Montesinos P, Sanz MA, Brenner B, Barbui T.

George Washington University, Washington, DC, USA, Nobis, Fall Church, VA, USA. frederick.rickles@noblis.org

Erratum in:

Thromb Res. 2008;123(1):187-90.

PMID: 18023721 [PubMed - indexed for MEDLINE]

 

 

Secretaría del Servicio de Hematología · Hospital General, Planta Baja · Hospital Universitario La Fe · Avda. Campanar 21 · 46021 Valencia. · Tfno.:963 862 745 · Fax: 961 973 281
Aviso legal · Mapa web
[X] Cerrar